RPRX
Royalty Pharma plc
Stock
$57.16−0.47 (−0.82%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.0B | $2.5B | $2.8B | $3.0B | $2.1B | $2.0B | $2.0B | $1.7B | $1.6B |
| Stock-based compensation | $428M | $290M | $2.3M | $2.4M | $2.2M | $2.4M | $5.4M | $0 | $0 |
| Buybacks | $322M | $1.2B | $230M | $305M | $0 | $0 | $0 | $4.3M | $0 |
| Dividends per share | $0.91 | — | $0.84 | $0.80 | $0.76 | $0.68 | $0.30 | — | — |